Amylyx Pharmaceuticals Announces Pricing of an Upsized $500 Million Underwritten Public Offering of Common Stock
Business Wire•19/08/2026•23:06 ET
0
Whiz Insights
Get started
Create a free account to read the full story.
Create a free account to read the full story.